Joseph, Nisha S. http://orcid.org/0000-0003-4001-9622
Kaufman, Jonathan L. http://orcid.org/0000-0002-5687-6429
Gupta, Vilas A. http://orcid.org/0000-0002-8980-2338
Hofmeister, Craig C. http://orcid.org/0000-0003-4816-1607
Dhodapkar, Madhav V. http://orcid.org/0000-0002-8249-5988
Boise, Lawrence H. http://orcid.org/0000-0001-9436-8815
DiCamillo, Sara M.
Roberts, Danielle
Nooka, Ajay K. http://orcid.org/0000-0003-4165-6869
Lonial, Sagar http://orcid.org/0000-0002-8322-9323
Article History
Received: 20 March 2024
Revised: 18 July 2024
Accepted: 1 August 2024
First Online: 13 September 2024
Competing interests
: Nisha S. Joseph has served on advisory boards and reports consultancy for Janssen Oncology, Bristol-Myers Squibb; research funding from Janssen, Bristol-Myers Squibb, Takeda, AstraZeneca, GSK. Jonathan L. Kaufman reports consultancy for and research funding from Janssen, Takeda, Bristol-Myers Squibb, Celgene, AbbVie, Roche, Seattle Genetics, Amgen, Sutro Biopharma, Karyopharm, Celgene, and Pharmacyclics outside the submitted work. Craig C. Hofmeister has served on an advisory board for Celgene and reports being the principal investigator of company-sponsored trials for Janssen, Celgene, Bristol-Myers Squibb, and Takeda-Millennium outside the submitted work. Ajay K. Nooka has served on advisory boards for Amgen, Spectrum Pharmaceuticals, Takeda Pharmaceuticals, Celgene, Bristol-Myers Squibb, GlaxoSmithKline, Adaptive Technologies, and Janssen Pharmaceuticals and reports grants from Amgen Pharmaceuticals, Takeda Pharmaceuticals, Bristol-Myers Squibb, Janssen Pharmaceuticals, Celgene, and GSK during the conduct of the study; he also reports grants from Novartis, Roche, and KITE outside the submitted work. Madhav V. Dhodapkar reports personal fees from Amgen and Janssen outside the submitted work. Sagar Lonial reports consultancy for and research funding from Takeda, Novartis, Bristol-Myers Squibb, GlaxoSmithKline, Amgen, Merck, Celgene, and Janssen outside the submitted work. The other authors made no disclosures.
: All data was de-identified and compiled as per our institutional IRB-approved protocol. Per IRB52278, we received a waiver of consent from Emory University IRB.